Exempting information in collaborative drug therapy agreements from disclosure under the public records act.

HB 2176 exempts collaborative drug therapy agreements - written plans between pharmacists and physicians for managing patient medications - from public disclosure under Washington’s public records law. These agreements, which outline how pharmacists can independently adjust medications under physician supervision, would remain confidential unless used as evidence in disciplinary actions against a licensed healthcare provider. The bill specifically prohibits disclosure of personally identifiable information (like names or contact details) in these agreements, except when the agreement directly leads to a disciplinary finding. This change primarily affects pharmacists, physicians, and healthcare facilities using such agreements, ensuring their operational details stay private while maintaining transparency in disciplinary cases.